Expensify, Inc.

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

EXFY$1.72-7.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at March 31, 2025	—	$—	92,383,667	$9	$288,639	$(153,997)	$134,651
Issuance of common stock on exercise of stock options	—	—	20,793	—	26	—	26
Vesting of early exercised stock options	—	—	—	—	25	—	25
Issuance of restricted stock units	—	—	1,515	—	5	—	5
Settlement of liability-classified restricted common shares	—	—	144,820	—	—	—	—
Issuance of common stock under Matching Plan	—	—	954,258	—	1,459	—	1,459
Issuance of common stock in connection with restricted stock units vesting	—	—	427,493	—	—	—	—
Repurchase and retirement of common stock	—	—	(1,285,336)	—	(3,026)	—	(3,026)
Stock-based compensation	—	—	—	—	7,463	—	7,463
Net loss	—	—	—	—	—	(8,788)	(8,788)
Balance at June 30, 2025	—	$—	92,647,210	$9	$294,591	$(162,785)	$131,815

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at March 31, 2024	—	$—	86,484,507	$9	$251,055	$(144,554)	$106,510
Issuance of common stock upon exercise of stock options	—	—	14,225	—	14	—	14
Vesting of early exercised stock options	—	—	—	—	106	—	106
Issuance of restricted stock units	—	—	8,971	—	17	—	17
Issuance of common stock under Matching Plan	—	—	1,422,832	—	1,090	—	1,090
Issuance of common stock in connection with restricted stock units vesting	—	—	264,155	—	—	—	—
Stock-based compensation	—	—	—	—	9,027	—	9,027
Net loss	—	—	—	—	—	(2,764)	(2,764)
Balance at June 30, 2024	—	$—	88,194,690	$9	$261,309	$(147,318)	$114,000

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at December 31, 2024	—	$—	91,376,765	$9	$279,062	$(150,828)	$128,243
Issuance of common stock on exercise of stock options	—	—	96,082	—	117	—	117
Vesting of early exercised stock options	—	—	—	—	113	—	113
Issuance of restricted stock units	—	—	6,472	—	23	—	23
Settlement of liability-classified restricted common shares	—	—	144,820	—	—	—	—
Issuance of common stock under Matching Plan	—	—	1,683,744	—	2,610	—	2,610
Issuance of common stock in connection with restricted stock units vesting	—	—	624,663	—	—	—	—
Repurchase and retirement of common stock	—	—	(1,285,336)	—	(3,026)	—	(3,026)
Stock-based compensation	—	—	—	—	15,692	—	15,692
Net loss	—	—	—	—	—	(11,957)	(11,957)
Balance at June 30, 2025	—	$—	92,647,210	$9	$294,591	$(162,785)	$131,815

See accompanying notes to Condensed Consolidated Financial Statements.

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at December 31, 2023	—	$—	85,225,328	$8	$241,509	$(140,773)	$100,744
Issuance of common stock upon exercise of stock options	—	—	56,529	—	53	—	53
Vesting of early exercised stock options	—	—	—	—	243	—	243
Issuance of restricted stock units	—	—	16,259	—	35	—	35
Repurchase of early exercised stock options	—	—	(30,434)	—	—	—	—
Issuance of common stock under Matching Plan	—	—	2,452,976	1	2,003	—	2,004
Issuance of common stock in connection with restricted stock units vesting	—	—	474,032	—	—	—	—
Stock-based compensation	—	—	—	—	17,466	—	17,466
Net loss	—	—	—	—	—	(6,545)	(6,545)
Balance at June 30, 2024	—	$—	88,194,690	$9	$261,309	$(147,318)	$114,000

See accompanying notes to Condensed Consolidated Financial Statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.